Clinical Trial Update: FTIH to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of GSK1322888 in Healthy Caucasian and Japanese Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated safety, tolerability, and pharmacokinetics of a single oral dose of GSK1322888 in healthy Caucasian and Japanese volunteers; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroparesis

Drugs mentioned

• GSK1322888

Snippet

Sponsor: GlaxoSmithKline | Conditions: Gastroparesis | Phase 1 | Status: COMPLETED